Hemophilia Clinical Trials
Have hemophilia B with 2 IUdL 2 endogenous FIX activity levels as documented by a certified clinical laboratory at the time of screening. We obtained HJHS scores from 107 PwHA. Clinical Trials For Gene Therapy Of Hemophilia Download Table A surge in therapeutic clinical trials over recent years is paving the way for transformative treatment options for patients with hemophilia. Hemophilia clinical trials . Individuals with hemophilia B suffer repeated bleeding events which can cause chronic joint disease and sometimes leads to death due to the inability for blood to clot efficiently. We are committed to advancing hemophilia patient care and facilitating the development of novel treatments through research studies and clinical trials. The goal of this research is to study the use of hemophilia treatment. The Inhibitor Prevention Trial is a 48-week randomized phase III trial in which 66 previously untreated patients PUPs with severe hemophilia. A Trial Comparing Nonacog Beta